Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens: Antibody response inhibition induced by immunization with a mixture of recombinants differing in virulence

Journal of General Virology

Volumn 80, Issue 11, 1999, Pages 2901-2908

  Kutinová, Luda ^a   Ludvíková, Viera ^a   Marešová, Lucie ^a   Němečková, Šárka ^a   Brouček, Jaroslav ^b   Hainz, Petr ^a   Vonka, Vladimír ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b Institute of Criminalistics   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VARICELLA ZOSTER VIRUS; VIRUS RECOMBINANT; VIRUS VIRULENCE;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 3; VACCINIA; VACCINIA VIRUS;

EID: 0344563615     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-11-2901     Document Type: Article

References (32)

1. Buller, R. M. L. & Palumbo, G. J. (1992). Safety and attenuation of vaccinia virus. In Recombinant Poxviruses, pp. 235-267. Edited by M. Binns & G. Smith. London: CRC Press.
2. Buller, R. M. L., Smith, G. L., Cremer, K., Notkins, A. L. & Moss, B. (1985). Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317, 813-815.
3. Christen, L., Seto, J. & Niles, E. G. (1990). Superinfection exclusion of vaccinia virus in virus-infected cell cultures. Virology 174, 35-42.
4. Fonseca, B. A. L., Pincus, S., Shope, R. E., Paoletti, E. & Mason, P. W. (1994). Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 12, 279-285.
5. Giavedoni, L., Jones, L., Mebus, C. & Yilma, T. (1991). A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proceedings of the National Academy of Sciences, USA 88, 8011-8015.
6. Grigorieva, I. M., Grigoriev, V. G., Zakharova, L. G., Pashvykina, G. V., Shevlyagin, V. Y. & Altstein, A. D. (1993). Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice. Immunology Letters 36, 267-272.
7. Hamšíková, E., Závadová, H., Kutinová, L., Ludvíková, V., Krchňák, V., Němečková, Š. & Vonka, V. (1990). Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen. Archives of Virology 113, 283-289.
8. Joklik, W. K. (1962). The purification of four strains of poxvirus. Virology 18, 9-18.
9. Kutinová, L., Němečková, Š., Hamšíková, E., Press, M., Závadová, H., Hirsch, I., Němeček, V., Krchňák, V., Smrt, J., Slonim, D. & Vonka, V. (1990). A recombinant vaccinia virus expressing hepatitis B virus middle surface protein. Restricted expression of HBV antigens in human diploid cells. Archives of Virology 112, 181-193.
10. Kutinová, L., Němečková, Š., Hamšíková, E., Závadová, H., Ludvíková, V., Brouček, J., Kunke, D., Konig, J., Zakharova, L. G., Pashvykina, G. V., Loparev, V. & Vonka, V. (1994). Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells. Archives of Virology 134, 1-15.
11. Kutinová, L., Ludvíková, V., Simonová, V., Otavová, M., Kryštofová, J., Hainz, P., Press, M., Kunke, D. & Vonka, V. (1995). Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine 13, 487-493.
12. Kutinová, L., Ludvíková, V., Kryštofová, J., Otavová, M., Simonová, V., Němečková, Š., Hainz, P. & Vonka, V. (1996). Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I. Vaccine 14, 1045-1052.
13. Kutinová, L., Ludvíková, V., Němečková, Š., Hainz, P., Simonová, V. & Vonka, V. (1999). Secondary vaccination with vaccinia virus recombinants: role of residual virulence of recombinants and immunogenicity of extrinsic antigens. Vaccine 17, 1186-1192.
14. Lee, M. S., Roos, J. M., McGuigan, L. C., Smith, K. A., Cormier, N., Cohen, L. K., Roberts, B. E. & Payne, L. G. (1992). Molecular attenuation of vaccinia virus: mutant generation and animal characterization. Journal of Virology 66, 2617-2630.
15. Ludvíková, V., Kunke, D., Hamšíková, E., Kutinová, L. & Vonka, V. (1991). Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant. Journal of General Virology 72, 1445-1449.
16. Mahr, A. & Payne, L. G. (1992). Vaccinia recombinants as vaccine vectors. Immunobiology 184, 126-146.
17. Morgan, A. J., Mackett, N., Finerty, S., Arrand, J. R., Scullion, F. T. & Epstein, M. A. (1988). Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas. Journal of Medical Virology 25, 189-195.
18. Moss, B. (1996). Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proceedings of the National Academy of Sciences, USA 93, 11341-11348.
19. Moss, B., Rosenblum, E. N. & Grimley, P. M. (1971). Assembly of virus particles during mixed infection with wild-type vaccinia and a rifampicin-resistant mutant. Virology 45, 135-148.
20. Němečková, Š., Kutinová, L., Hamšíková, E., Kunke, D., Press, M., Závadová, H., Smrt, J. & Vonka, V. (1991). Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw. Archives of Virology 121, 29-41.
21. Němečková, Š., Ludvíková, V., Marešová, L., Kryštofová, J., Hainz, P. & Kutinová, L. (1996). Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene. Journal of General Virology 77, 211-215.
22. Perkus, M. E., Piccini, A., Lipinskas, B. R. & Paoletti, E. (1985). Recombinant vaccinia virus: immunization against multiple pathogens. Science 229, 981-984.
23. Perkus, M. E., Panicali, D., Mercer, S. & Paoletti, E. (1986). Insertion and deletion mutants of vaccinia virus. Virology 152, 285-297.
24. Perkus, M. E., Tartaglia, J. & Paoletti, E. (1995). Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases. Journal of Leukocyte Biology 58, 1-13.
25. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27, 493-497.
26. Rodriguez, D., Rodriguez, J. R., Rodriguez, J. F., Trauber, D. & Esteban, M. (1989). Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proceedings of the National Academy of Sciences, USA 86, 1287-1291.
27. Shida, H. & Matsumoto, S. (1983). Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope. Cell 33, 423-434.
28. Shida, H., Hinuma, Y., Hatanaka, M., Morita, M., Kidokoro, M., Suzuki, K., Maruyama, T., Takahashi-Nishimaki, F., Sugimoto, M., Kitamura, R., Miyazawa, T. & Hayami, M. (1988). Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene. Journal of Virology 62, 4474-4480.
29. Tartaglia, J., Perkus, M. E., Taylor, J., Norton, E. K., Audonnet, J. C., Cox, W. I., Davis, S. W., van der Hoeven, J., Meignier, B., Riviere, M., Languet, B. & Paoletti, E. (1992). NYVAC: a highly attenuated strain of vaccinia virus. Virology 188, 217-232.
30. Taylor, J., Weinberg, R., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D., Appel, M., Norton, E. & Paoletti, E. (1992). Nonrepeating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187, 321-328.
31. Tine, J. A., Lanar, D. E., Smith, D. M., Wellde, B. T., Schultheiss, P., Ware, L. A., Kauffman, E. B., Wirtz, R. A., De Taisne, C., Hui, G. S. N., Chang, S. P., Church, P., Hollingdale, M. R., Kaslow, D. C., Hoffman, S., Guito, K. P., Ballou, W. R., Sadoff, J. C. & Paoletti, E. (1996). NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium fakiparum malaria. Infection and Immunity 64, 3833-3844.
32. Wild, T. F., Bernard, A., Spehner, D. & Drillien, R. (1992). Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Journal of General Virology 73, 359-367.